Researcher Profile

Researcher Profile

Chandra Belani, MD

Chandra Belani, MD

Professor, Department of Medicine
Division of Hematology and Oncology
Scientific Program:Experimental Therapeutics
Disease Teams:
Thoracic Cancer

Research Interests

  • Non-Small Cell Lung Carcinoma
  • Therapeutics
  • Lung Neoplasms
  • Neoplasms
  • Carboplatin
  • Paclitaxel
  • Drug Therapy
  • Survival
  • Cisplatin
  • docetaxel
  • Radiotherapy
  • Pharmacokinetics

Clinical Trials

MATCH Treatment Subprotocol C2: Crizotinib in Patients with Tumors with MET Exon 14 Deletion
MATCH Treatment Subprotocol E: AZD9291 in Patients with Tumors Having EGFR T790M Mutations (Except Non-Small Cell Lung Cancer) or Rare Activating Mutations of EGFR
MATCH Treatment Subprotocol F: Crizotinib in Patients with Tumors (Other Than Adenocarcinoma of Lung or ALCL) with ALK Rearrangements
MATCH Treatment Subprotocol G: Phase II Study of Crizotinib in Patients with ROS1 Translocations (Other Than Patients with Non-Small Cell Lung Cancer)
MATCH Treatment Subprotocol L: Phase II Study of MLN0128 (TAK-228) in Patients with Tumors with mTOR Mutations
MATCH Treatment Subprotocol M: Phase II Study of MLN0128 (TAK-228) in Patients with Tumors with TSC1 or TSC2 Mutations
MATCH Treatment Subprotocol S2: Phase II Study of Trametinib in Patients with Tumors with GNAQ or GNA11 mutations
MATCH Treatment Subprotocol T: GDC-0449 (vismodegib) in Patients with Tumors (except basal cell skin carcinoma) with Smoothened (SMO) or Patched 1 (PTCH1) Mutations
MATCH Treatment Subprotocol V: Phase II Study of Sunitinib in Patients with Tumors with c-Kit Mutations (Excluding GIST, Renal Cell Carcinoma or Pancreatic Neuroendocrine Tumor).
Oncogenic Mutations/Gene Rearrangements in Patients with Advanced Adenocarcinoma Lung
Characterization of Oncogenic Mutations in Patients with Advanced Squamous Cell Lung Cancer
Oncogenic Driver Mutations/Biomarkers in Screening Participants for Early Detection of Lung Cancer
One Time Tissue and Blood Collection from Patients with Lung Cancer at Risk for Developing Lung Cancer
Observational Study to Determine the Differences in Molecular Characterization between Smokers vs. Non-smokers in Patients with Stage IV Bladder Cancer and their Correlation with Clinical Outcome
Tissue and Blood Collection from Patients with Suspected Lung Cancer

Recent Publications


Rice, SJ, Liu, X, Zhang, J & Belani, C 2019, 'Absolute Quantification of All Identified Plasma Proteins from SWATH Data for Biomarker Discovery', Proteomics, vol. 19, no. 3, 1800135.
Rice, SJ, Liu, X, Zhang, J, Jia, B, Zheng, H & Belani, C 2019, 'Advanced NSCLC patients with high IL-6 levels have altered peripheral T cell population and signaling', Lung Cancer, vol. 131, pp. 58-61.
Rice, SJ, Liu, X, Wang, HG & Belani, C 2019, 'EGFR mutations and AKT phosphorylation are markers for sensitivity to combined MCL-1 and BCL-2/xL inhibition in non-small cell lung cancer', PloS one, vol. 14, no. 5, e0217657.
Videtic, GM, Paulus, R, Singh, AK, Chang, JY, Parker, W, Olivier, KR, Timmerman, RD, Komaki, RR, Urbanic, JJ, Stephans, KL, Yom, SS, Robinson, CG, Belani, C, Iyengar, P, Ajlouni, MI, Gopaul, DD, Gomez Suescun, JB, McGarry, RC, Choy, H & Bradley, JD 2019, 'Long-term Follow-up on NRG Oncology RTOG 0915 (NCCTG N0927): A Randomized Phase 2 Study Comparing 2 Stereotactic Body Radiation Therapy Schedules for Medically Inoperable Patients With Stage I Peripheral Non-Small Cell Lung Cancer', International Journal of Radiation Oncology Biology Physics, vol. 103, no. 5, pp. 1077-1084.
Yin, R, Rice, SJ, Wang, J, Gao, L, Tsai, J, Anvari, RT, Zhou, F, Liu, X, Wang, G, Tang, Y, Mihm, MC, Belani, C, Chen, DB, Nelson, JS & Tan, W 2019, 'Membrane trafficking and exocytosis are upregulated in port wine stain blood vessels', Histology and histopathology, vol. 34, no. 5, pp. 479-490.
Reckamp, KL, Frankel, PH, Ruel, N, Mack, PC, Gitlitz, BJ, Li, T, Koczywas, M, Gadgeel, SM, Cristea, MC, Belani, C, Newman, EM, Gandara, DR & Lara, PN 2019, 'Phase II trial of cabozantinib plus erlotinib in patients with advanced epidermal growth factor receptor (EGFR)-mutant non-small cell lung cancer with progressive disease on epidermal growth factor receptor tyrosine kinase inhibitor therapy: A California cancer consortium phase II trial (NCI 9303)', Frontiers in Oncology, vol. 9, no. MAR, 132.
CASSINI Investigators 2019, 'Rivaroxaban for thromboprophylaxis in high-risk ambulatory patients with cancer', New England Journal of Medicine, vol. 380, no. 8, pp. 720-728.
Tian, S, Zhang, X, Jiang, R, Pillai, RN, Owonikoko, TK, Steuer, CE, Saba, NF, Pakkala, S, Patel, PR, Belani, C, Khuri, FR, Curran, WJ, Ramalingam, SS, Behera, M & Higgins, KA 2019, 'Survival Outcomes With Thoracic Radiotherapy in Extensive-Stage Small-Cell Lung Cancer: A Propensity Score-Matched Analysis of the National Cancer Database', Clinical Lung Cancer.


Liu, SV, Groshen, SG, Kelly, K, Reckamp, KL, Belani, C, Synold, TW, Goldkorn, A, Gitlitz, BJ, Cristea, MC, Gong, IY, Semrad, TJ, Xu, Y, Xu, T, Koczywas, M, Gandara, DR & Newman, EM 2018, 'A phase I trial of topotecan plus tivantinib in patients with advanced solid tumors', Cancer Chemotherapy and Pharmacology, vol. 82, no. 4, pp. 723-732.
Zhang, L, Belani, C, Zhang, PH, Wang, X, Yang, L, Orlando, M & Wu, YL 2018, 'Dynamic change of fatigue of pemetrexed maintenance treatment in the JMEN trial' Lung Cancer, vol. 115, pp. 121-126.
Varlotto, JM, Voland, R, McKie, K, Flickinger, JC, DeCamp, MM, Maddox, D, Rava, P, Fitzgerald, TJ, Graeber, G, Rassaei, N, Oliveira, P, Ali, S, Belani, C, Glanzman, J, Wakelee, HA, Patel, M, Baima, J, Zhang, J & Walsh, W 2018, 'Population-based differences in the outcome and presentation of lung cancer patients based upon racial, histologic, and economic factors in all lung patients and those with metastatic disease', Cancer medicine, vol. 7, no. 4, pp. 1211-1220.


Belani, C, Chakraborty, BC, Modi, RI & Khamar, B 2017, 'A randomized trial of TLR-2 agonist CADI-05 targeting desmocollin-3 for advanced non-small-cell lung cancer', Annals of Oncology, vol. 28, no. 2, pp. 298-304.
Steuer, CE, Behera, M, Ernani, V, Higgins, KA, Saba, NF, Shin, DM, Pakkala, S, Pillai, RN, Owonikoko, TK, Curran, WJ, Belani, C, Khuri, FR & Ramalingam, SS 2017, 'Comparison of concurrent use of thoracic radiation with either carboplatin-paclitaxel or cisplatin-etoposide for patients with stage III non–small-cell lung cancer: A systematic review', JAMA Oncology, vol. 3, no. 8, pp. 1120-1129.
Pillai, RN, Behera, M, Owonikoko, TK, Kamphorst, AO, Pakkala, S, Belani, C, Khuri, FR, Ahmed, R & Ramalingam, SS 2018, 'Comparison of the toxicity profile of PD-1 versus PD-L1 inhibitors in non–small cell lung cancer: A systematic analysis of the literature', Cancer, vol. 124, no. 2, pp. 271-277.
Higgins, KA, O'Connell, K, Liu, Y, Gillespie, TW, McDonald, MW, Pillai, RN, Patel, KR, Patel, PR, Robinson, CG, Simone, CB, Owonikoko, TK, Belani, C, Khuri, FR, Curran, WJ, Ramalingam, SS & Behera, M 2017, 'National Cancer Database Analysis of Proton Versus Photon Radiation Therapy in Non-Small Cell Lung Cancer', International Journal of Radiation Oncology Biology Physics, vol. 97, no. 1, pp. 128-137.
Stoller, R, Schmitz, JC, Ding, F, Puhalla, S, Belani, C, Appleman, L, Lin, Y, Jiang, Y, Almokadem, S, Petro, D, Holleran, J, Kiesel, BF, Ken Czambel, R, Carneiro, BA, Kontopodis, E, Hershberger, PA, Rachid, M, Chen, A, Chu, E & Beumer, JH 2017, 'Phase I study of veliparib in combination with gemcitabine', Cancer Chemotherapy and Pharmacology, vol. 80, no. 3, pp. 631-643.
Liegey Dougall, A, Swanson, J, Kyutoku, Y, Belani, C & Baum, A 2017, 'Posttraumatic Symptoms, Quality of Life, and Survival among Lung Cancer Patients', Journal of Applied Biobehavioral Research, vol. 22, no. 3, e12065.
Wan, Y, Cheng, G, Liu, X, Hao, SJ, Nisic, M, Zhu, CD, Xia, YQ, Li, WQ, Wang, ZG, Zhang, WL, Rice, SJ, Sebastian, A, Albert, I, Belani, C & Zheng, S 2017, 'Rapid magnetic isolation of extracellular vesicles via lipid-based nanoprobes', Nature Biomedical Engineering, vol. 1, no. 4, 0058.
Khorana, AA, Vadhan-Raj, S, Kuderer, NM, Wun, T, Liebman, H, Soff, G, Belani, C, O'Reilly, EM, McBane, R, Eikelboom, J, Damaraju, CV, Beyers, K, Dietrich, F, Kakkar, AK, Riess, H, Peixoto, RDA & Lyman, GH 2017, 'Rivaroxaban for preventing venous thromboembolism in high-risk ambulatory patients with cancer: Rationale and design of the CASSINI trial', Thrombosis and Haemostasis, vol. 117, no. 11, pp. 2135-2145.


Liu, X, Rice, SJ, Jamis-Dow, CA, Abendroth, C, Ali, S, Almokadem, S & Belani, C 2016, 'A patient with complex multiple genomic alk alterations' Thorax, vol. 71, no. 4, pp. 383-385.
Aronson, KR, Wagstaff, DA, Farace, E, Muscat, J, Belani, C, Almokadem, S & Fossum, T 2016, 'A week in the life of lung cancer survivors: Daily reports of stress, worry, mood, and symptoms', Journal of Health Psychology, vol. 21, no. 10, pp. 2269-2282.
Liu, X & Belani, C 2016, 'Clinical advances in immuno-oncology-progress towards selective cure', Current Molecular Pharmacology, vol. 9, no. 3.
Rice, SJ, Miller, B, Wagman, M, Jamorabo, DS, Liu, X & Belani, C 2016, 'Clinical approaches to immunotherapy in non-small cell lung cancer: Current and future perspectives', Current Molecular Pharmacology, vol. 9, no. 3, pp. 183-195.
MAR-LC Collaborative Group 2016, 'Difference in restricted mean survival time for cost-effectiveness analysis using individual patient data meta-analysis: Evidence from a case study', PloS one, vol. 11, no. 3, e0150032.
Gerber, DE, Spigel, DR, Giorgadze, D, Shtivelband, M, Ponomarova, OV, Shan, JS, Menander, KB & Belani, C 2016, 'Docetaxel Combined with Bavituximab in Previously Treated, Advanced Nonsquamous Non-Small-Cell Lung Cancer', Clinical Lung Cancer, vol. 17, no. 3, pp. 169-176.
Zheng, H, Liu, X, Zhang, J, Rice, SJ, Wagman, M, Kong, Y, Zhu, L, Zhu, J, Joshi, M & Belani, C 2016, 'Expression of PD-1 on CD4+ T cells in peripheral blood associates with poor clinical outcome in non-small cell lung cancer', Oncotarget, vol. 7, no. 35, pp. 56233-56240.
Joshi, M, Millis, SZ, Arguello, D, Holder, S, Lamm, D, Reddy, S, Belani, C, Drabick, J & Vogelzang, NJ 2018, 'Molecular Characterization of Bladder Cancer in Smokers versus Nonsmokers', European Urology Focus, vol. 4, no. 1, pp. 94-97.
Wang, H, Liu, X, Rice, SJ & Belani, C 2016, 'Pulmonary Rehabilitation in Lung Cancer', PM and R, vol. 8, no. 10, pp. 990-996.
Ardizzoni, A, Tiseo, M, Boni, L, Di Maio, M, Buffoni, L, Belvedere, O, Grossi, F, D'Alessandro, V, de Marinis, F, Barbera, S, Caroti, C, Favaretto, A, Cortinovis, D, Morrica, B, Tixi, L, Ceschia, T, Parisi, S, Ricardi, U, Grimaldi, A, Loreggian, L, Navarria, P, Huber, RM, Belani, C, Bruswig, PF, Scagliotti, GV & Scolaro, T 2016, 'Randomized phase III PITCAP trial and meta-analysis of induction chemotherapy followed by thoracic irradiation with or without concurrent taxane-based chemotherapy in locally advanced NSCLC' Lung Cancer, vol. 100, pp. 30-37.
Behera, M, Ragin, C, Kim, S, Pillai, RN, Chen, Z, Steuer, CE, Saba, NF, Belani, C, Khuri, FR, Ramalingam, SS & Owonikoko, TK 2016, 'Trends, predictors, and impact of systemic chemotherapy in small cell lung cancer patients between 1985 and 2005', Cancer, vol. 122, no. 1, pp. 50-60.
Belani, C, Dahlberg, SE, Rudin, CM, Fleisher, M, Chen, HX, Takebe, N, Velasco, MR, Tester, WJ, Sturtz, K, Hann, CL, Shanks, JC, Monga, M, Ramalingam, SS & Schiller, JH 2016, 'Vismodegib or cixutumumab in combination with standard chemotherapy for patients with extensive-stage small cell lung cancer: A trial of the ECOG-ACRIN cancer research group (E1508)', Cancer, vol. 122, no. 15, pp. 2371-2378.


Owonikoko, TK, Dahlberg, SE, Khan, SA, Gerber, DE, Dowell, J, Moss, RA, Belani, C, Hann, CL, Aggarwal, C & Ramalingam, SS 2015, 'A phase 1 safety study of veliparib combined with cisplatin and etoposide in extensive stage small cell lung cancer: A trial of the ECOG-ACRIN Cancer Research Group (E2511)', Lung Cancer, vol. 89, no. 1, pp. 66-70.
Appleman, LJ, Balasubramaniam, S, Parise, RA, Bryla, C, Redon, CE, Nakamura, AJ, Bonner, WM, Wright, JJ, Piekarz, R, Kohler, DR, Jiang, Y, Belani, C, Eiseman, J, Chu, E, Beumer, JH & Bates, SE 2015, 'A phase I study of DMS612, a novel bifunctional alkylating agent' Clinical Cancer Research, vol. 21, no. 4, pp. 721-729.
Joshi, M, Rizvi, SM & Belani, C 2015, 'Afatinib for the treatment of metastatic non-small cell lung cancer' Cancer Management and Research, vol. 7, pp. 75-82.
Behera, M, Pillai, RN, Owonikoko, TK, Kim, S, Steuer, C, Chen, Z, Saba, NF, Belani, C, Khuri, FR & Ramalingam, SS 2015, 'Bevacizumab in combination with taxane versus non-taxane containing regimens for advanced/metastatic nonsquamous non-small-cell lung cancer a systematic review', Journal of Thoracic Oncology, vol. 10, no. 8, pp. 1142-1147.
Jamorabo, DS, Belani, C & Martin, EW 2015, 'Complex chronic conditions in Rhode Island's pediatric populace: Implications for palliative and hospice services, 2000-2012' Journal of palliative medicine, vol. 18, no. 4, pp. 350-357.
Xiang, D, Yuan, Y, Chen, L, Liu, X, Belani, C & Cheng, H 2015, 'Niclosamide, an anti-helminthic molecule, downregulates the retroviral oncoprotein Tax and pro-survival Bcl-2 proteins in HTLV-1-transformed T lymphocytes' Biochemical and Biophysical Research Communications, vol. 464, no. 1, pp. 221-228.
Varlotto, JM, Yao, AN, Decamp, MM, Ramakrishna, S, Recht, A, Flickinger, J, Andrei, A, Reed, MF, Toth, J, Fizgerald, TJ, Higgins, K, Zheng, X, Shelkey, J, Medford-Davis, LN, Belani, C & Kelsey, CR 2015, 'Nodal stage of surgically resected non-small cell lung cancer and its effect on recurrence patterns and overall survival', International Journal of Radiation Oncology Biology Physics, vol. 91, no. 4, pp. 765-773.
Rice, SJ, Liu, X, Miller, B, Joshi, M, Zhu, J, Caruso, C, Gilbert, C, Toth, J, Reed, MF, Rassaei, N, Das, A, Barochia, A, El-Bayoumy, K & Belani, C 2015, 'Proteomic profiling of human plasma identifies apolipoprotein E as being associated with smoking and a marker for squamous metaplasia of the lung' Proteomics, vol. 15, no. 18, pp. 3267-3277.
Das, A, Bortner, JD, Aliaga, C, Cooper, T, Stanley, A, Stanley, B, Belani, C & El-Bayoumy, K 2015, 'Proteomic profiling of hyperplasia/atypia and adenoma-induced by NNK in mouse lung identified multiple proteins as potential biomarkers for early detection' EuPA Open Proteomics, vol. 9, pp. 23-33.
Ramalingam, SS, Shtivelband, M, Soo, RA, Barrios, CH, Makhson, A, Segalla, JGM, Pittman, KB, Kolman, P, Pereira, JR, Srkalovic, G, Belani, C, Axelrod, R, Owonikoko, TK, Qin, Q, Qian, J, McKeegan, EM, Devanarayan, V, McKee, MD, Ricker, JL, Carlson, DM & Gorbunova, VA 2015, 'Randomized phase II study of carboplatin and paclitaxel with either linifanib or placebo for advanced nonsquamous non-small-cell lung cancer', Journal of Clinical Oncology, vol. 33, no. 5, pp. 433-442.
Niu, G, Zhang, H, Liu, D, Chen, L, Belani, C, Wang, H-G & Cheng, H 2015, 'Tid1, the mammalian homologue of Drosophila tumor suppressor Tid56, mediates macroautophagy by interacting with beclin1-containing autophagy protein complex', Journal of Biological Chemistry, vol. 290, no. 29, pp. 18102-18110.
Joshi, M, Rice, SJ, Liu, X, Miller, B & Belani, C 2015, 'Trametinib with or without Vemurafenib in braf mutated non-small cell lung cancer' PLoS One, vol. 10, no. 2, 0118210.

Clinical Trials Search

Children (age < 18 years)
Adults (age >= 18 years)